- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-477/21: Judgment of the General Court of 24 May 2023 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler) (EU trade mark — Invalidity proceedings — Three-dimensional EU trade mark — Shape of an inhaler — Absolute ground for invalidity — Distinctive character acquired through use — Article 51(2) of Regulation (EC) No 40/94 (now Article 59(2) of Regulation (EU) 2017/1001) — Obligation to state reasons — Article 94 of Regulation 2017/1001)
ECLI:EU:UNKNOWN:62021TA0477
62021TA0477
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 252/40
(Case T-477/21) (1)
(EU trade mark - Invalidity proceedings - Three-dimensional EU trade mark - Shape of an inhaler - Absolute ground for invalidity - Distinctive character acquired through use - Article 51(2) of Regulation (EC) No 40/94 (now Article 59(2) of Regulation (EU) 2017/1001) - Obligation to state reasons - Article 94 of Regulation 2017/1001)
(2023/C 252/45)
Language of the case: English
Parties
Applicant: Glaxo Group Ltd (Brentford, United Kingdom) (represented by: T. de Haan and F. Verhoestraete, lawyers)
Defendant: European Union Intellectual Property Office (represented by: D. Gája and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Cipla Europe NV (Antwerp, Belgium)
Re:
By its action under Article 263 TFEU, the applicant seeks annulment of the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 19 May 2021 (Case R 1835/2016-1).
Operative part of the judgment
The Court:
1.Annuls the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 19 May 2021 (Case R 1835/2016-1);
2.Orders EUIPO to pay the costs, including those incurred for the purposes of the proceedings before the Board of Appeal.
*
(1)
Language of the case: English
ECLI:EU:C:2023:140